“the-column-group” Archives

in
Entry Author Date Location
FLX Bio Secures $50,000,000 Series B Financing 04/30/16 San Francisco
“Raw Potential” And Three Other Takeaways from NY’s Life Science Disruptors 03/30/16 New York
Stealthy MIT Spinout Ribon, Led by a Sanofi Vet, Takes Aim at Cancer 03/03/16 Boston
With $48M For Petra Pharma, Accelerator Places First NYC Bet 01/06/16 New York
East Coast Biotech Roundup: ASH, Kallyope, SQZ, Kyras & More 12/11/15 Boston
Kallyope Receives $44,000,000 Series A Funding 12/11/15 New York
With Startup, Bio Pioneer Tom Maniatis Looks to Spark NY Scene Again 12/10/15 New York
Constellation Pharmaceuticals Lands $55,000,000 New Funding Round 12/10/15 Boston
With Drugs in Clinic, Constellation Nabs $55M For IPO Push 12/09/15 Boston
West Coast Bio Roundup: Gene Edit Talk, Not Poor ORIC, BioMarin Sags 12/04/15 San Francisco
ORIC Pharmaceuticals Receives $53,000,000 Series B Round 12/03/15 San Francisco
Led By Biotech Stars, ORIC Nabs $53M To Fight Drug-Resistant Cancer 12/02/15 San Francisco
Neurona Therapeutics Receives $23,500,000 Series A Round 12/02/15 San Francisco
Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology 10/20/15 San Francisco
Celgene Cozies up to Nurix With $150M Drug Development Deal 09/16/15 San Francisco
Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes 03/03/15 National
Yes to Flexus: The Science And Strategy Behind A Huge Biotech Return 02/26/15 San Francisco
Flexus Speeds From Inception to $1.25B Bristol Buyout In Less Than Two Years 02/23/15 San Francisco
West Coast Biotech Roundup: Gilead/AbbVie, Juno, Auspex, Bina & More 12/23/14 San Francisco
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More 12/19/14 Boston
VenBio Scores Again as Genentech Pays $1.7B+ for Seragon Pharma 07/02/14 San Diego
West Coast Biotech Roundup: Ligand, Ardelyx, Mango Health, and More 05/23/14 San Diego
As Expected, Nurix Taps Into $25M for New Drug Discovery 05/22/14 San Francisco
Two San Francisco Startups Sharing In Third Rock’s Rich Third Fund 04/24/14 San Francisco
Igenica Follows Genentech Into Antibody-Linked Cancer Drugs 04/11/14 San Francisco
Igenica Lands $14,000,000 Series C Financing Round 01/28/14 San Francisco
Immune Design Grabs $32.5M, Cashing in on Cancer Immunotherapy Rush 10/30/13 Seattle
Immune Design Garners $49,000,000 Series C Financing 10/30/13 Seattle
Seragon Pharmaceuticals Obtains $30,000,000 Series A Financing 10/18/13 San Diego
NGM, Partners Seek Next Diabetes Drug Targets Among GI Tract Hormones 06/25/13 San Francisco
Page 1 of 3 next page »